VANCOMYCIN: payments to doctors
Payments that named VANCOMYCIN as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $32K
- Providers
- 11
- Transactions
- 32
- Average per transaction
- $1,003
The per-transaction average — $1,003 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 11 providers the average total is $2,918, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Xellia Pharmaceuticals | $32,049 | 99.9% |
| Pfizer | $46 | 0.1% |